Active ingredient
Pegloticase NDC Codes
Pegloticase is an active ingredient in 2 finished products listed with the FDA, under 1 name.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Krystexxa
- Labelers
- Horizon Therapeutics USA, Inc.
- Strengths
- Pegloticase 8 mg/50mL; Pegloticase 8 mg/mL
- Dosage forms
- Injection, Solution
- Routes
- Intravenous
- Drug classes (FDA established)
- Uric Acid-specific Enzyme
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 2
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Krystexxapegloticase | Pegloticase 8 mg/50mL | Injection, SolutionIntravenous | Horizon Therapeutics USA, Inc. | 75987-058 | 75987-0058-01 | — |
| Krystexxapegloticase | Pegloticase 8 mg/mL | Injection, SolutionIntravenous | Horizon Therapeutics USA, Inc. | 75987-080 | 75987-0080-10 | — |
Pegloticase: common questions
- Which drugs contain Pegloticase?
- Krystexxa.
- Is there a J-code for Pegloticase?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.